JP5281411B2 - 胃から食道への逆流の治療に適した医療器具 - Google Patents
胃から食道への逆流の治療に適した医療器具 Download PDFInfo
- Publication number
- JP5281411B2 JP5281411B2 JP2008546830A JP2008546830A JP5281411B2 JP 5281411 B2 JP5281411 B2 JP 5281411B2 JP 2008546830 A JP2008546830 A JP 2008546830A JP 2008546830 A JP2008546830 A JP 2008546830A JP 5281411 B2 JP5281411 B2 JP 5281411B2
- Authority
- JP
- Japan
- Prior art keywords
- medical device
- esophagus
- support member
- configuration
- stomach
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003238 esophagus Anatomy 0.000 title claims description 123
- 210000002784 stomach Anatomy 0.000 title claims description 64
- 238000010992 reflux Methods 0.000 title claims description 13
- 238000011282 treatment Methods 0.000 title description 35
- 239000000463 material Substances 0.000 claims description 54
- 239000003814 drug Substances 0.000 claims description 49
- 229940079593 drug Drugs 0.000 claims description 23
- 239000012528 membrane Substances 0.000 claims description 17
- 239000006261 foam material Substances 0.000 claims description 5
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 80
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 37
- 238000000034 method Methods 0.000 description 34
- 229940124597 therapeutic agent Drugs 0.000 description 26
- 229920000642 polymer Polymers 0.000 description 21
- 235000013305 food Nutrition 0.000 description 18
- 210000001519 tissue Anatomy 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 16
- 230000007246 mechanism Effects 0.000 description 16
- 210000005070 sphincter Anatomy 0.000 description 16
- 230000006870 function Effects 0.000 description 15
- 230000002265 prevention Effects 0.000 description 12
- 239000006260 foam Substances 0.000 description 11
- 230000004888 barrier function Effects 0.000 description 10
- 210000001072 colon Anatomy 0.000 description 10
- 210000003205 muscle Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 7
- 230000009747 swallowing Effects 0.000 description 7
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 210000003038 endothelium Anatomy 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 5
- 230000000151 anti-reflux effect Effects 0.000 description 5
- 230000001413 cellular effect Effects 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 150000007523 nucleic acids Chemical class 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000012781 shape memory material Substances 0.000 description 4
- 229920005830 Polyurethane Foam Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 239000002783 friction material Substances 0.000 description 3
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000000017 hydrogel Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000008855 peristalsis Effects 0.000 description 3
- 239000011496 polyurethane foam Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003190 viscoelastic substance Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 108020004459 Small interfering RNA Proteins 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000004308 accommodation Effects 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- -1 aminoglycosides Chemical compound 0.000 description 2
- 238000004873 anchoring Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000227 bioadhesive Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- ZKMNUMMKYBVTFN-HNNXBMFYSA-N (S)-ropivacaine Chemical compound CCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C ZKMNUMMKYBVTFN-HNNXBMFYSA-N 0.000 description 1
- LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 1
- ASVKKRLMJCWVQF-UHFFFAOYSA-N 3-buten-1-amine Chemical group NCCC=C ASVKKRLMJCWVQF-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
- 206010050456 Anastomotic leak Diseases 0.000 description 1
- 102400000068 Angiostatin Human genes 0.000 description 1
- 108010079709 Angiostatins Proteins 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- 229940123587 Cell cycle inhibitor Drugs 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- PTOAARAWEBMLNO-KVQBGUIXSA-N Cladribine Chemical compound C1=NC=2C(N)=NC(Cl)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 PTOAARAWEBMLNO-KVQBGUIXSA-N 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 102400001047 Endostatin Human genes 0.000 description 1
- 108010079505 Endostatins Proteins 0.000 description 1
- 206010063655 Erosive oesophagitis Diseases 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 208000034991 Hiatal Hernia Diseases 0.000 description 1
- 206010020028 Hiatus hernia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical class [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- GSNOZLZNQMLSKJ-UHFFFAOYSA-N Trapidil Chemical compound CCN(CC)C1=CC(C)=NC2=NC=NN12 GSNOZLZNQMLSKJ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000002998 adhesive polymer Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- FZCSTZYAHCUGEM-UHFFFAOYSA-N aspergillomarasmine B Natural products OC(=O)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O FZCSTZYAHCUGEM-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960003150 bupivacaine Drugs 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 229960002436 cladribine Drugs 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 229960000975 daunorubicin Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960004679 doxorubicin Drugs 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 206010057271 eosinophilic colitis Diseases 0.000 description 1
- 229930013356 epothilone Natural products 0.000 description 1
- 150000003883 epothilone derivatives Chemical class 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- LVASCWIMLIKXLA-LSDHHAIUSA-N halofuginone Chemical compound O[C@@H]1CCCN[C@H]1CC(=O)CN1C(=O)C2=CC(Cl)=C(Br)C=C2N=C1 LVASCWIMLIKXLA-LSDHHAIUSA-N 0.000 description 1
- 229950010152 halofuginone Drugs 0.000 description 1
- 229940077716 histamine h2 receptor antagonists for peptic ulcer and gord Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229960004023 minocycline Drugs 0.000 description 1
- DYKFCLLONBREIL-KVUCHLLUSA-N minocycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=CC(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O DYKFCLLONBREIL-KVUCHLLUSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XLFWDASMENKTKL-UHFFFAOYSA-N molsidomine Chemical compound O1C(N=C([O-])OCC)=C[N+](N2CCOCC2)=N1 XLFWDASMENKTKL-UHFFFAOYSA-N 0.000 description 1
- 229960004027 molsidomine Drugs 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- NXFQHRVNIOXGAQ-YCRREMRBSA-N nitrofurantoin Chemical compound O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)NC(=O)C1 NXFQHRVNIOXGAQ-YCRREMRBSA-N 0.000 description 1
- 229960000564 nitrofurantoin Drugs 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 1
- 229960001225 rifampicin Drugs 0.000 description 1
- 229960001549 ropivacaine Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000004683 skeletal myoblast Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000001057 smooth muscle myoblast Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000000152 swallowing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229960000363 trapidil Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2476—Valves implantable in the body not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00818—Treatment of the gastro-intestinal system
- A61B2017/00827—Treatment of gastro-esophageal reflux
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/044—Oesophagi or esophagi or gullets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75288105P | 2005-12-23 | 2005-12-23 | |
| US60/752,881 | 2005-12-23 | ||
| PCT/IE2006/000145 WO2007072469A2 (en) | 2005-12-23 | 2006-12-22 | A medical device suitable for treating reflux from a stomach to an oesophagus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009520559A JP2009520559A (ja) | 2009-05-28 |
| JP2009520559A5 JP2009520559A5 (enExample) | 2010-01-28 |
| JP5281411B2 true JP5281411B2 (ja) | 2013-09-04 |
Family
ID=37905641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008546830A Expired - Fee Related JP5281411B2 (ja) | 2005-12-23 | 2006-12-22 | 胃から食道への逆流の治療に適した医療器具 |
Country Status (6)
| Country | Link |
|---|---|
| US (5) | US9308077B2 (enExample) |
| EP (1) | EP1968487B1 (enExample) |
| JP (1) | JP5281411B2 (enExample) |
| AU (1) | AU2006327539A1 (enExample) |
| CA (2) | CA2853623C (enExample) |
| WO (1) | WO2007072469A2 (enExample) |
Families Citing this family (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7766973B2 (en) * | 2005-01-19 | 2010-08-03 | Gi Dynamics, Inc. | Eversion resistant sleeves |
| US20040143342A1 (en) * | 2003-01-16 | 2004-07-22 | Stack Richard S. | Satiation pouches and methods of use |
| US9308077B2 (en) | 2005-12-23 | 2016-04-12 | Vysera Biomedical Limited | Medical device suitable for treating reflux from a stomach to an oesophagus |
| US7892250B2 (en) * | 2006-11-01 | 2011-02-22 | Ethicon Endo-Surgery, Inc. | Use of biosurgical adhesive on inflatable device for gastric restriction |
| US8084154B2 (en) * | 2007-02-08 | 2011-12-27 | Karl Frederick Scheucher | Battery pack safety and thermal management apparatus and method |
| US20100329993A1 (en) * | 2007-06-29 | 2010-12-30 | Hiroyuki Yoneyama | Method of fixing and expressing physiologically active substance |
| US20090093837A1 (en) * | 2007-10-09 | 2009-04-09 | Wilson-Cook Medical Inc. | Anastomosis plug for bariatric surgery |
| US20090138093A1 (en) * | 2007-11-27 | 2009-05-28 | Minos Medical | System and method for esophageal sphincter repair |
| US9833240B2 (en) | 2008-02-18 | 2017-12-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| US9393002B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
| US9044235B2 (en) | 2008-02-18 | 2015-06-02 | Covidien Lp | Magnetic clip for implant deployment device |
| US8808314B2 (en) | 2008-02-18 | 2014-08-19 | Covidien Lp | Device and method for deploying and attaching an implant to a biological tissue |
| US8758373B2 (en) | 2008-02-18 | 2014-06-24 | Covidien Lp | Means and method for reversibly connecting a patch to a patch deployment device |
| US9034002B2 (en) | 2008-02-18 | 2015-05-19 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| US9301826B2 (en) | 2008-02-18 | 2016-04-05 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| US9393093B2 (en) | 2008-02-18 | 2016-07-19 | Covidien Lp | Clip for implant deployment device |
| US8317808B2 (en) | 2008-02-18 | 2012-11-27 | Covidien Lp | Device and method for rolling and inserting a prosthetic patch into a body cavity |
| US9398944B2 (en) | 2008-02-18 | 2016-07-26 | Covidien Lp | Lock bar spring and clip for implant deployment device |
| ATE554731T1 (de) * | 2008-05-16 | 2012-05-15 | Sorin Biomedica Cardio Srl | Atraumatische prothetische herzklappenprothese |
| GB0810749D0 (en) | 2008-06-11 | 2008-07-16 | Angiomed Ag | Catherter delivery device |
| US9750625B2 (en) | 2008-06-11 | 2017-09-05 | C.R. Bard, Inc. | Catheter delivery device |
| ES2659081T3 (es) * | 2008-06-20 | 2018-03-13 | Coloplast A/S | Un biomaterial |
| US8500821B2 (en) | 2008-06-20 | 2013-08-06 | Vysera Biomedical Limited | Esophageal valve device for placing in the cardia |
| US20100114327A1 (en) * | 2008-06-20 | 2010-05-06 | Vysera Biomedical Limited | Valve |
| WO2010039100A1 (en) * | 2008-09-30 | 2010-04-08 | Jerry Borander | Air flow adjustment |
| AU2009305958B9 (en) | 2008-10-20 | 2013-07-11 | Covidien Lp | A device for attaching a patch to a biological tissue |
| US20100131043A1 (en) * | 2008-11-26 | 2010-05-27 | Casas Jesus W | Endoluminal Implants For Bioactive Material Delivery |
| US8253210B2 (en) * | 2009-04-30 | 2012-08-28 | Infineon Technologies Ag | Semiconductor device including a magnetic sensor chip |
| US20110022026A1 (en) * | 2009-07-21 | 2011-01-27 | Lake Region Manufacturing, Inc. d/b/a Lake Region Medical. Inc. | Methods and Devices for Delivering Drugs Using Drug-Delivery or Drug-Coated Guidewires |
| CA2769666C (en) | 2009-08-17 | 2018-02-13 | Arie Levy | Means and method for reversibly connecting an implant to a deployment device |
| WO2011021083A1 (en) | 2009-08-17 | 2011-02-24 | PolyTouch Medical, Inc. | Articulating patch deployment device and method of use |
| US9211182B2 (en) | 2009-11-20 | 2015-12-15 | E2, Llc | Anti-reflux devices and methods for treating gastro-esophageal reflux disease (GERD) |
| EP3360916A1 (en) | 2009-12-18 | 2018-08-15 | Coloplast A/S | A biomaterial |
| US8876800B2 (en) | 2009-12-18 | 2014-11-04 | Vysera Biomedical Limited | Urological device |
| WO2011073970A1 (en) | 2009-12-18 | 2011-06-23 | Vysera Biomedical Limited | A gastrointestinal implant device |
| WO2011073968A1 (en) | 2009-12-18 | 2011-06-23 | Vysera Biomedical Limited | A drug delivery system |
| US20110270016A1 (en) * | 2010-04-29 | 2011-11-03 | Allergan, Inc. | Self-adjusting gastric band |
| US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
| US20110277778A1 (en) * | 2010-05-14 | 2011-11-17 | Tyco Healthcare Group Lp | System and Method for Diverticulitis Treatment |
| US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
| US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
| US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US8992410B2 (en) | 2010-11-03 | 2015-03-31 | Vysera Biomedical Limited | Urological device |
| JP5967779B2 (ja) | 2010-11-03 | 2016-08-10 | コロプラスト アクティーゼルスカブ | 泌尿器用デバイス |
| EP2484309B1 (en) | 2011-02-02 | 2019-04-10 | Shlomo Gabbay | Heart valve prosthesis |
| GB2488530A (en) * | 2011-02-18 | 2012-09-05 | David J Wheatley | Heart valve |
| US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
| US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| AU2012259125B2 (en) * | 2011-05-20 | 2016-06-02 | Bfkw, Llc | Intraluminal device and method with enhanced anti-migration |
| US10285798B2 (en) | 2011-06-03 | 2019-05-14 | Merit Medical Systems, Inc. | Esophageal stent |
| US9999767B2 (en) | 2011-06-27 | 2018-06-19 | E-Motion Medical, Ltd. | Esophageal stimulation system |
| US8986368B2 (en) | 2011-10-31 | 2015-03-24 | Merit Medical Systems, Inc. | Esophageal stent with valve |
| EP3888602A1 (en) | 2011-12-19 | 2021-10-06 | Coloplast A/S | A luminal prosthesis and a gastrointestinal implant device |
| JP6324371B2 (ja) * | 2012-04-06 | 2018-05-16 | マーリン エムディー プライベート リミテッド | 動脈瘤を治療するためのデバイスおよび方法 |
| US9314325B2 (en) | 2012-04-27 | 2016-04-19 | Cook Medical Technologies Llc | Anti-aspiration prosthesis |
| US9427303B2 (en) | 2012-04-27 | 2016-08-30 | Cook Medical Technologies Llc | Anti-aspiration valve |
| US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
| US9687367B2 (en) | 2012-06-05 | 2017-06-27 | Merit Medical Systems, Inc. | Esophageal stent |
| US9510934B2 (en) * | 2012-07-20 | 2016-12-06 | Cook Medical Technologies Llc | Implantable medical device having a sleeve |
| US20140031951A1 (en) * | 2012-07-27 | 2014-01-30 | Cook Medical Technologies Llc | Two-Way Valve |
| WO2014022500A1 (en) * | 2012-07-31 | 2014-02-06 | The Charles Stark Draper Laboratory, Inc. | Implantable device for directional control of flow within the anatomic tracts of the body |
| EP2911611B1 (en) | 2012-10-24 | 2022-12-07 | Cook Medical Technologies LLC | Anti-reflux prosthesis |
| JP6302933B2 (ja) | 2012-12-24 | 2018-03-28 | イーエモーション メディカル エルティーディー.E−Motion Medical Ltd. | 胃腸管刺激装置 |
| EP2752170B1 (en) | 2013-01-08 | 2017-02-22 | Cook Medical Technologies LLC | Multi valve anti-reflux prosthesis |
| RU2658453C2 (ru) | 2013-03-05 | 2018-06-21 | Мерит Медикал Системз, Инк. | Упрочненный клапан |
| WO2014150130A1 (en) | 2013-03-15 | 2014-09-25 | Merit Medical Systems, Inc. | Esophageal stent |
| US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
| US9775591B2 (en) * | 2013-11-21 | 2017-10-03 | Edwards Lifesciences Corporation | Sealing devices and related delivery apparatuses |
| US10383756B2 (en) * | 2014-03-14 | 2019-08-20 | Boston Scientific Scimed, Inc. | Intragastric balloon delivery systems and methods |
| DE202016008737U1 (de) | 2015-12-15 | 2019-04-05 | Neovasc Tiara Inc. | Transseptales Zuführsystem |
| US10149754B2 (en) * | 2016-01-20 | 2018-12-11 | Sujay Kumar Shad | Suturing ring for prosthetic heart valves |
| CN108882981B (zh) | 2016-01-29 | 2021-08-10 | 内奥瓦斯克迪亚拉公司 | 用于防止流出阻塞的假体瓣膜 |
| JP2017140244A (ja) | 2016-02-10 | 2017-08-17 | テルモ株式会社 | 処置方法、および医療装置 |
| US10456237B2 (en) * | 2016-03-07 | 2019-10-29 | Boston Scientific Scimed, Inc. | Esophageal stent including a valve member |
| US10779980B2 (en) * | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| CN109996581B (zh) | 2016-11-21 | 2021-10-15 | 内奥瓦斯克迪亚拉公司 | 用于快速收回经导管心脏瓣膜递送系统的方法和系统 |
| CA3073834A1 (en) | 2017-08-25 | 2019-02-28 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
| US11272835B2 (en) * | 2017-11-09 | 2022-03-15 | Corinth MedTech, Inc. | Surgical devices and methods |
| CN111601545B (zh) | 2017-11-09 | 2024-05-07 | 康沃特克科技公司 | 造口术监测系统和方法 |
| US11446080B2 (en) | 2018-01-30 | 2022-09-20 | Corinth MedTech, Inc. | Surgical device and methods |
| USD893514S1 (en) | 2018-11-08 | 2020-08-18 | 11 Health And Technologies Limited | Display screen or portion thereof with graphical user interface |
| WO2020093172A1 (en) | 2018-11-08 | 2020-05-14 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
| EP3914200B1 (en) * | 2019-01-22 | 2026-03-11 | Lean Medical Technologies, Inc. | Obesity treatment device |
| JP6904987B2 (ja) * | 2019-01-31 | 2021-07-21 | センチュリーメディカル株式会社 | ステント |
| WO2020185597A1 (en) | 2019-03-08 | 2020-09-17 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
| US11602429B2 (en) | 2019-04-01 | 2023-03-14 | Neovasc Tiara Inc. | Controllably deployable prosthetic valve |
| EP3952792A4 (en) | 2019-04-10 | 2023-01-04 | Neovasc Tiara Inc. | HEART VALVE PROSTHESIS WITH NATURAL BLOOD FLOW |
| CN111543992A (zh) * | 2019-05-10 | 2020-08-18 | 华中科技大学同济医学院附属协和医院 | 一种可调式集成pH-阻抗双模块导管 |
| EP3972673B1 (en) | 2019-05-20 | 2026-01-28 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
| CN114144144B (zh) | 2019-06-20 | 2026-01-13 | 内奥瓦斯克迪亚拉公司 | 低轮廓假体二尖瓣 |
| EP3941390A1 (en) * | 2019-07-12 | 2022-01-26 | Boston Scientific Scimed Inc. | Stents and methods for managing passage of material through a body lumen |
| US12336751B2 (en) | 2019-08-26 | 2025-06-24 | Aulea Medical, Inc. | Surgical device and methods |
| US20210346437A1 (en) * | 2020-05-07 | 2021-11-11 | Board Of Trustees Of Southern Illinois University | Novel treatment of dysphagia |
| JP7565707B2 (ja) * | 2020-05-14 | 2024-10-11 | 勇 佐伯 | 食道閉鎖症治療具 |
| CA3198681A1 (en) | 2020-10-15 | 2022-04-21 | Convatec Technologies Inc. | Ostomy systems and methods |
| KR102930660B1 (ko) * | 2021-05-19 | 2026-02-24 | 보스톤 싸이엔티픽 싸이메드 인코포레이티드 | 이식형 디바이스를 통한 통로를 조정하기 위한 시스템 |
| US12575875B2 (en) | 2021-12-17 | 2026-03-17 | Aulea Medical, Inc. | Surgical device and methods |
Family Cites Families (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1354691A (en) | 1970-02-12 | 1974-05-30 | Black M M | Fluid-operated valves |
| US4265694A (en) * | 1978-12-14 | 1981-05-05 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Method of making unitized three leaflet heart valve |
| US4271827A (en) * | 1979-09-13 | 1981-06-09 | Angelchik Jean P | Method for prevention of gastro esophageal reflux |
| US4378224A (en) * | 1980-09-19 | 1983-03-29 | Nimni Marcel E | Coating for bioprosthetic device and method of making same |
| US4603152A (en) * | 1982-11-05 | 1986-07-29 | Baxter Travenol Laboratories, Inc. | Antimicrobial compositions |
| FR2600524B1 (fr) * | 1986-01-13 | 1991-10-18 | Galtier Claude | Oesophage artificiel. |
| US4932948A (en) * | 1988-03-28 | 1990-06-12 | Hollister Incorporated | Male external catheter and antimicrobial insert therefor |
| US4846836A (en) * | 1988-10-03 | 1989-07-11 | Reich Jonathan D | Artificial lower gastrointestinal valve |
| WO1990004431A1 (en) * | 1988-10-20 | 1990-05-03 | Chen Fusen H | Incontinence device |
| US5800339A (en) * | 1989-02-09 | 1998-09-01 | Opticon Medical Inc. | Urinary control valve |
| US4932938A (en) * | 1989-05-05 | 1990-06-12 | Medical Engineering Corporation | Urethral indwelling catheter with incontinence control |
| CH680263A5 (enExample) | 1989-07-20 | 1992-07-31 | Norman Godin | |
| US5314473A (en) * | 1989-07-20 | 1994-05-24 | Godin Norman J | Prosthesis for preventing gastric reflux into the esophagus |
| US5088980A (en) | 1990-05-31 | 1992-02-18 | The United States Of America As Represented By The Department Of Health And Human Services | Intra-urethral valve with integral spring |
| US5140999A (en) * | 1991-09-30 | 1992-08-25 | Primed International Corp. | Urinary incontinence valve device |
| US5443498A (en) * | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
| US5395349A (en) * | 1991-12-13 | 1995-03-07 | Endovascular Technologies, Inc. | Dual valve reinforced sheath and method |
| BE1006440A3 (fr) * | 1992-12-21 | 1994-08-30 | Dereume Jean Pierre Georges Em | Endoprothese luminale et son procede de preparation. |
| US5536258A (en) * | 1994-02-14 | 1996-07-16 | Fresenius Usa, Inc. | Antibacterial medical tubing connector |
| US5549657A (en) * | 1994-05-12 | 1996-08-27 | C.R. Bard, Inc. | Low profile adaptor for gastrostomy feeding tube |
| US5599305A (en) * | 1994-10-24 | 1997-02-04 | Cardiovascular Concepts, Inc. | Large-diameter introducer sheath having hemostasis valve and removable steering mechanism |
| US5624374A (en) * | 1994-11-03 | 1997-04-29 | Von Iderstein; Irwin F. | Involuntary urine control apparatus, system and method |
| US5609629A (en) * | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
| US5701916A (en) | 1995-08-16 | 1997-12-30 | Hk Medical Technologies Incorporated | Intraurethral bladder control device with retainer apparatus |
| US6050934A (en) * | 1997-02-26 | 2000-04-18 | Cv Dynamics, Inc. | Urinary catheter having palpitatable discharge valve with protective shoulders |
| US5887594A (en) * | 1997-09-22 | 1999-03-30 | Beth Israel Deaconess Medical Center Inc. | Methods and devices for gastroesophageal reflux reduction |
| US6254642B1 (en) * | 1997-12-09 | 2001-07-03 | Thomas V. Taylor | Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof |
| US6113609A (en) * | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
| US6066088A (en) * | 1998-07-13 | 2000-05-23 | Phillip Davis Inventions, Inc. | Intraurethral magnetic valve |
| AU6131499A (en) * | 1998-08-27 | 2000-03-21 | Endonetics, Inc. | Lower esophageal bulking device |
| US6264700B1 (en) * | 1998-08-27 | 2001-07-24 | Endonetics, Inc. | Prosthetic gastroesophageal valve |
| US6746489B2 (en) * | 1998-08-31 | 2004-06-08 | Wilson-Cook Medical Incorporated | Prosthesis having a sleeve valve |
| US7118600B2 (en) * | 1998-08-31 | 2006-10-10 | Wilson-Cook Medical, Inc. | Prosthesis having a sleeve valve |
| PT1109511E (pt) * | 1998-08-31 | 2004-03-31 | Wilson Cook Medical Inc | Protese esofagica anti-refluxo |
| US6494879B2 (en) | 1998-10-15 | 2002-12-17 | Scimed Life Systems, Inc. | Treating urinary retention |
| US6251064B1 (en) * | 1998-12-11 | 2001-06-26 | Enteric Medical Technologies, Inc. | Method for creating valve-like mechanism in natural body passageway |
| US6234956B1 (en) * | 1999-08-11 | 2001-05-22 | Hongping He | Magnetic actuation urethral valve |
| US6458153B1 (en) * | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
| US6976950B2 (en) * | 2000-04-14 | 2005-12-20 | Solace Therapeutics, Inc. | Implantable valved pressure attenuation device |
| US6921361B2 (en) * | 2000-07-24 | 2005-07-26 | Olympus Corporation | Endoscopic instrument for forming an artificial valve |
| WO2002022054A1 (en) * | 2000-09-12 | 2002-03-21 | Gabbay S | Valvular prosthesis and method of using same |
| US6432040B1 (en) * | 2000-09-14 | 2002-08-13 | Nizam N. Meah | Implantable esophageal sphincter apparatus for gastroesophageal reflux disease and method |
| US7011094B2 (en) * | 2001-03-02 | 2006-03-14 | Emphasys Medical, Inc. | Bronchial flow control devices and methods of use |
| US20020143387A1 (en) * | 2001-03-27 | 2002-10-03 | Soetikno Roy M. | Stent repositioning and removal |
| US6726696B1 (en) * | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
| US7087088B2 (en) * | 2001-05-24 | 2006-08-08 | Torax Medical, Inc. | Methods and apparatus for regulating the flow of matter through body tubing |
| US20030069635A1 (en) * | 2001-05-29 | 2003-04-10 | Cartledge Richard G. | Prosthetic heart valve |
| US6958079B1 (en) * | 2001-07-03 | 2005-10-25 | Reflux Corporation | Perorally insertable/removable anti-reflux valve |
| FR2826863B1 (fr) | 2001-07-04 | 2003-09-26 | Jacques Seguin | Ensemble permettant la mise en place d'une valve prothetique dans un conduit corporel |
| US6638253B2 (en) * | 2001-07-17 | 2003-10-28 | Eugene Michael Breznock | Method and apparatus for chest drainage |
| US6675809B2 (en) | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
| US6790237B2 (en) * | 2001-10-09 | 2004-09-14 | Scimed Life Systems, Inc. | Medical stent with a valve and related methods of manufacturing |
| US6921378B2 (en) * | 2001-10-09 | 2005-07-26 | Boston Scientific Scimed, Inc. | Anti-reflux drainage devices and methods |
| GB0125925D0 (en) * | 2001-10-29 | 2001-12-19 | Univ Glasgow | Mitral valve prosthesis |
| US7146984B2 (en) * | 2002-04-08 | 2006-12-12 | Synecor, Llc | Method and apparatus for modifying the exit orifice of a satiation pouch |
| US7047980B2 (en) * | 2002-04-09 | 2006-05-23 | Promethean Surgical Devices Llc | Treatment for Gastroesophageal disease |
| US7001367B2 (en) * | 2002-04-16 | 2006-02-21 | Arkinstall William W | Valved ostomy drainage device |
| US6908447B2 (en) * | 2002-04-18 | 2005-06-21 | Scimed Life Systems, Inc. | Anti-reflux ureteral stents and methods |
| US6960233B1 (en) * | 2002-12-10 | 2005-11-01 | Torax Medical, Inc. | Methods and apparatus for improving the function of biological passages |
| US7270675B2 (en) * | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
| US7033384B2 (en) * | 2002-08-30 | 2006-04-25 | Satiety, Inc. | Stented anchoring of gastric space-occupying devices |
| KR100442330B1 (ko) * | 2002-09-03 | 2004-07-30 | 주식회사 엠아이텍 | 스텐트 및 이 스텐트의 제조방법 |
| SI1539798T1 (sl) * | 2002-09-06 | 2011-03-31 | Genentech Inc | Postopek za proteinsko ekstrakcijo |
| US8282678B2 (en) | 2002-11-13 | 2012-10-09 | Allium Medical Solutions Ltd. | Endoluminal lining |
| US20040102855A1 (en) * | 2002-11-21 | 2004-05-27 | Scimed Life Systems, Inc. | Anti-reflux stent |
| US8034048B2 (en) * | 2003-05-05 | 2011-10-11 | Boston Scientific Scimed, Inc. | Tissue patches and related delivery systems and methods |
| US7416546B2 (en) * | 2003-05-05 | 2008-08-26 | Boston Scientific Scimed, Inc. | Tissue patches and related delivery systems and methods |
| CA2537307A1 (en) | 2003-09-02 | 2005-04-14 | Biomedix S.A. | Gastrointestinal anti-reflux prosthesis apparatus and method |
| US7815589B2 (en) | 2003-12-09 | 2010-10-19 | Gi Dynamics, Inc. | Methods and apparatus for anchoring within the gastrointestinal tract |
| EP1703870B1 (en) | 2003-12-19 | 2019-05-01 | Patrick Leahy | An anti-reflux system |
| US7261732B2 (en) * | 2003-12-22 | 2007-08-28 | Henri Justino | Stent mounted valve |
| US20050228505A1 (en) * | 2004-03-29 | 2005-10-13 | Cornet Douglas A | Device and method for treating gastroesophageal reflux disease |
| US7470247B2 (en) * | 2004-04-26 | 2008-12-30 | Gyrus Acmi, Inc. | Ureteral stent |
| US20060135971A1 (en) * | 2004-05-07 | 2006-06-22 | Usgi Medical Inc. | System for treating gastroesophageal reflux disease |
| US7351369B2 (en) * | 2004-06-21 | 2008-04-01 | King Technology | Molded twist-on wire connector |
| US20060041189A1 (en) * | 2004-08-17 | 2006-02-23 | Vancaillie Thierry G | Grummet |
| US7833281B2 (en) * | 2004-12-15 | 2010-11-16 | Lehman Glen A | Method and apparatus for augmentation of a sphincter |
| KR100691503B1 (ko) * | 2005-03-21 | 2007-03-09 | (주) 태웅메디칼 | 식도용 스텐트 |
| FR2883721B1 (fr) | 2005-04-05 | 2007-06-22 | Perouse Soc Par Actions Simpli | Necessaire destine a etre implante dans un conduit de circulation du sang, et endoprothese tubulaire associee |
| US7914569B2 (en) * | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
| US7666180B2 (en) * | 2005-05-20 | 2010-02-23 | Tyco Healthcare Group Lp | Gastric restrictor assembly and method of use |
| TW200745159A (en) * | 2005-07-13 | 2007-12-16 | Avidia Inc | IL-6 binding proteins |
| US20080269879A1 (en) * | 2005-07-27 | 2008-10-30 | Rahul Dilip Sathe | Implantable Prosthetic Vascular Valve |
| WO2007016165A1 (en) * | 2005-07-29 | 2007-02-08 | Cook Incorporated | Elliptical implantable device |
| US7601361B2 (en) * | 2005-10-03 | 2009-10-13 | E. I. Du Pont De Nemours And Company | Process for providing antimicrobial surfaces |
| US9308077B2 (en) | 2005-12-23 | 2016-04-12 | Vysera Biomedical Limited | Medical device suitable for treating reflux from a stomach to an oesophagus |
| WO2007107990A2 (en) | 2006-03-20 | 2007-09-27 | Svip 2 Llc | Pyloric devices and methods |
| US7524331B2 (en) * | 2006-04-06 | 2009-04-28 | Medtronic Vascular, Inc. | Catheter delivered valve having a barrier to provide an enhanced seal |
| EP2010270A4 (en) | 2006-04-07 | 2014-07-09 | Valentx Inc | DEVICES AND METHOD FOR A ENDOLUMINAL STOMACH BY-PASS |
| US7819836B2 (en) * | 2006-06-23 | 2010-10-26 | Gi Dynamics, Inc. | Resistive anti-obesity devices |
| US7722665B2 (en) * | 2006-07-07 | 2010-05-25 | Graft Technologies, Inc. | System and method for providing a graft in a vascular environment |
| US20080051879A1 (en) * | 2006-08-23 | 2008-02-28 | Cook Incorporated | Methods of treating venous valve related conditions with a flow-modifying implantable medical device |
| WO2008046092A2 (en) * | 2006-10-13 | 2008-04-17 | Creighton University | Implantable valve prosthesis |
| US8105392B2 (en) * | 2006-11-08 | 2012-01-31 | Boston Scientific Scimed, Inc. | Pyloric obesity valve |
| US7678144B2 (en) * | 2007-01-29 | 2010-03-16 | Cook Incorporated | Prosthetic valve with slanted leaflet design |
| WO2008121409A1 (en) | 2007-03-29 | 2008-10-09 | Jaime Vargas | Intragastric implant devices |
| AU2008288796B2 (en) * | 2007-08-23 | 2014-03-20 | Dfm, Llc | Cardiovascular prosthetic valve |
| US7806921B2 (en) * | 2007-11-08 | 2010-10-05 | Cook Incorporated | Monocusp valve design |
| US8100962B2 (en) * | 2008-01-08 | 2012-01-24 | Cook Medical Technologies Llc | Flow-deflecting prosthesis for treating venous disease |
| CA2715448C (en) * | 2008-02-25 | 2017-06-13 | Medtronic Vascular Inc. | Infundibular reducer devices |
| US8100850B2 (en) | 2008-04-09 | 2012-01-24 | E2 Llc | Pyloric valve devices and methods |
| US8226593B2 (en) | 2008-04-09 | 2012-07-24 | E2 Llc | Pyloric valve |
| EP2293827A4 (en) | 2008-05-16 | 2017-08-16 | Maurice M. Garcia | Catheter drainage system |
| WO2010011878A2 (en) * | 2008-07-24 | 2010-01-28 | Cook Incorporated | Valve device with biased leaflets |
| CA2739326A1 (en) * | 2008-10-10 | 2010-04-15 | Intervalve, Inc. | Valvuloplasty catheter and methods |
| US20100131049A1 (en) * | 2008-11-24 | 2010-05-27 | Medtronic Vascular, Inc. | One-Way valve Prosthesis for Percutaneous Placement Within the Venous System |
| EP2413849B1 (en) | 2009-04-03 | 2014-07-02 | Metamodix, Inc. | Modular gastrointestinal prostheses |
| US20100312225A1 (en) * | 2009-06-03 | 2010-12-09 | John Anderson Armistead | Wholly indwelling, valve-actuated, urinary catheter |
| EP2451411B1 (en) | 2009-07-10 | 2016-06-01 | Metamodix, Inc. | External anchoring configurations for modular gastrointestinal prostheses |
| US8512313B2 (en) | 2009-11-03 | 2013-08-20 | Advanced Urological Products | Urinary flow control valve with pressure sealing |
-
2006
- 2006-12-22 US US11/643,698 patent/US9308077B2/en active Active
- 2006-12-22 CA CA2853623A patent/CA2853623C/en active Active
- 2006-12-22 EP EP06821554.0A patent/EP1968487B1/en not_active Not-in-force
- 2006-12-22 WO PCT/IE2006/000145 patent/WO2007072469A2/en not_active Ceased
- 2006-12-22 AU AU2006327539A patent/AU2006327539A1/en not_active Abandoned
- 2006-12-22 CA CA2634891A patent/CA2634891C/en active Active
- 2006-12-22 JP JP2008546830A patent/JP5281411B2/ja not_active Expired - Fee Related
-
2009
- 2009-06-18 US US12/487,308 patent/US20100036504A1/en not_active Abandoned
-
2010
- 2010-07-15 US US12/837,023 patent/US8603188B2/en not_active Expired - Fee Related
- 2010-07-15 US US12/837,032 patent/US8603189B2/en not_active Expired - Fee Related
-
2016
- 2016-02-29 US US15/055,858 patent/US20160175086A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20070198048A1 (en) | 2007-08-23 |
| EP1968487A2 (en) | 2008-09-17 |
| CA2853623C (en) | 2017-03-21 |
| US20160175086A1 (en) | 2016-06-23 |
| AU2006327539A1 (en) | 2007-06-28 |
| US9308077B2 (en) | 2016-04-12 |
| US8603188B2 (en) | 2013-12-10 |
| CA2634891C (en) | 2014-09-23 |
| CA2634891A1 (en) | 2007-06-28 |
| US20100280613A1 (en) | 2010-11-04 |
| WO2007072469A3 (en) | 2007-08-16 |
| US20100036504A1 (en) | 2010-02-11 |
| JP2009520559A (ja) | 2009-05-28 |
| US20100298951A1 (en) | 2010-11-25 |
| CA2853623A1 (en) | 2007-06-28 |
| WO2007072469A2 (en) | 2007-06-28 |
| EP1968487B1 (en) | 2019-06-26 |
| US8603189B2 (en) | 2013-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009520559A (ja) | 胃から食道への逆流の治療に適した医療器具 | |
| US12502290B2 (en) | Anti-migration micropatterned stent coating | |
| JP5065427B2 (ja) | 肥満症治療用スリーブ | |
| JP4669480B2 (ja) | 腸内スリーブ | |
| CN104887365B (zh) | 用于支持斑块贴靠血管壁的钉装置 | |
| CN106963530B (zh) | 内腔假体 | |
| CN102781369B (zh) | 用于肥胖症治疗的系统 | |
| US20150088048A1 (en) | Intragastic implant devices | |
| US10596021B2 (en) | Obesity treatment devices, systems, and methods | |
| JP2019519264A (ja) | 肥満治療用アンカーレス胃内デバイス | |
| KR101932830B1 (ko) | 접착제의 도포를 포함하는 전개 시스템 | |
| AU2017265169B2 (en) | A medical device suitable for treating reflux from a stomach to an oesophagus | |
| IE20060946A1 (en) | A medical device suitable for treating reflux from a stomach to an oesophagus | |
| AU2013219164A1 (en) | A medical device suitable for treating reflux from a stomach to an oesophagus | |
| EP2651348A1 (en) | A gastrointestinal implant device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091201 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091201 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20111221 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111226 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120316 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120326 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120605 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121101 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121102 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130509 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130524 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5281411 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D02 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |